Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study. (2021)
https://pubmed.ncbi.nlm.nih.gov/33427620/

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (2020)
https://pubmed.ncbi.nlm.nih.gov/33334727/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32755721/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32552128/

Toxicological considerations in the treatment of axial spondylo-arthritis. (2020)
https://pubmed.ncbi.nlm.nih.gov/32552128/